Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study. Issue 12 (17th December 2020)

• Record Type: Journal Article
• Authors: Elimian, Kelly Osezele; Ochu, Chinwe Lucia; Ebhodaghe, Blessing; Myles, Puja; Crawford, Emily E; Igumbor, Ehimario; Ukponu, Winifred; Olayinka, Adobola; Aruna, Olusola; Dan-Nwafor, Chioma; Olawepo, Olatayo Ayodeji; Ogunbode, Oladipo; Atteh, Rhoda; Nwachukwu, William; Venkatesan, Sudhir; Obagha, Chijioke; Ngishe, Samuel; Suleiman, Kabir; Usman, Muhammad; Yusuff, Hakeem Abiola; Nwadiuto, Ifeoma; Mohammed, Abbas Aliyu; Usman, Rabi; Mba, Nwando; Aderinola, Olaolu; Ilori, Elsie; Oladejo, John; Abubakar, Ibrahim; Ihekweazu, Chikwe
• Is Part Of: BMJ open. Volume 10:Issue 12(2020)
• Publication Date: 2020-12-17
• Subjects: respiratory infections -- public health -- epidemiology; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-044079
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objective: Despite the increasing disease burden, there is a dearth of context-specific evidence on the risk factors for COVID-19 positivity and subsequent death in Nigeria. Thus, the study objective was to identify context-specific factors associated with testing positive for COVID-19 and fatality in Nigeria. Design: Retrospective cohort study. Setting: COVID-19 surveillance and laboratory centres in 36 states and the Federal Capital Territory reporting data to the Nigeria Centre for Disease Control. Participants: Individuals who were investigated for SARS-CoV-2 using real-time PCR testing during the study period 27 February–8 June 2020. Methods: COVID-19 positivity and subsequent mortality. Multivariable logistic regression analyses were performed to identify factors independently associated with both outcome variables, and findings are presented as adjusted ORs (aORs) and 95% CIs. Results: A total of 36 496 patients were tested for COVID-19, with 10 517 confirmed cases. Of 3215 confirmed cases with available clinical outcomes, 295 died. Factors independently associated with COVID-19 positivity were older age (p value for trend<0.0001), male sex (aOR 1.11, 95% CI 1.04 to 1.18) and the following presenting symptoms: cough (aOR 1.23, 95% CI 1.13 to 1.32), fever (aOR 1.45, 95% CI 1.45 to 1.71), loss of smell (aOR 7.78, 95% CI 5.19 to 11.66) and loss of taste (aOR 2.50, 95% CI 1.60 to 3.90). An increased risk of mortality following COVID-19 was observed in those aged ≥51 years, patients in farming occupation (aOR 7.56, 95% CI 1.70 to 33.53) and those presenting with cough (aOR 2.06, 95% CI 1.41 to 3.01), breathing difficulties (aOR 5.68, 95% CI 3.77 to 8.58) and vomiting (aOR 2.54, 95% CI 1.33 to 4.84). Conclusion: The significant risk factors associated with COVID-19 positivity and subsequent mortality in the Nigerian population are similar to those reported in studies from other countries and should guide clinical decisions for COVID-19 testing and specialist care referrals.